Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study

Kathleen M O’Reilly, Frank Sandman, David Allen, Christopher I Jarvis, Amy Gimma, Amy Douglas, Lesley Larkin, Kerry LM Wong, Marc Baguelin, Ralph S Baric, Lisa C Lindesmith, Richard A Goldstein, Judith Breuer, W John Edmunds
doi: https://doi.org/10.1101/2021.07.09.21260277
Kathleen M O’Reilly
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kathleen.oreilly@lshtm.ac.uk
Frank Sandman
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
2Statistics, Modelling and Economics Department, National Infection Service, Public Health England, London, UK
3NIHR Health Protection Research Unit in Modelling and Health Economics, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Allen
4Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher I Jarvis
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Gimma
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy Douglas
5Gastrointestinal Pathogens Unit, National Infection Service, Public Health England, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lesley Larkin
5Gastrointestinal Pathogens Unit, National Infection Service, Public Health England, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerry LM Wong
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Baguelin
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
6MRC Centre for Global Infectious Disease Analysis, J-IDEA, Department of Infectious Disease Epidemiology, Imperial College London, St Mary’s Campus, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ralph S Baric
7Department of Epidemiology, University of North Carolina, Chapel Hill, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa C Lindesmith
7Department of Epidemiology, University of North Carolina, Chapel Hill, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard A Goldstein
8Division of Infection and Immunity, University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Judith Breuer
8Division of Infection and Immunity, University College London, London, UK
9Department of Microbiology, Virology and Infection Control, Great Ormond Street Hospital for Children, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W John Edmunds
1Centre for Mathematical Modelling of Infectious Diseases, Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To reduce the coronavirus disease burden in England, along with many other countries, the Government implemented a package of non-pharmaceutical interventions (NPIs) that have also impacted other transmissible infectious diseases such as norovirus. It is unclear what future norovirus disease incidence is likely to look like upon lifting these restrictions.

Methods Here we use a mathematical model of norovirus fitted to community incidence data in England to project forward expected incidence based on contact surveys that have been collected throughout 2020-2021.

Results We report that susceptibility to norovirus infection has likely increased between March 2020 to mid-2021. Depending upon assumptions of future contact patterns incidence of norovirus that is similar to pre-pandemic levels or an increase beyond what has been previously reported is likely to occur once restrictions are lifted. Should adult contact patterns return to 80% of pre-pandemic levels the incidence of norovirus will be similar to previous years. If contact patterns return to pre-pandemic levels there is a potential for the expected annual incidence to be up to 2-fold larger than in a typical year. The age-specific incidence is similar across all ages.

Conclusions Continued national surveillance for endemic diseases such as norovirus will be essential after NPIs are lifted to allow healthcare services to adequately prepare for a potential increase in cases and hospital pressures beyond what is typically experienced.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

The study is a simulation, no data were collected as part of the study

Funding Statement

This research was primarily funded by the Wellcome Trust Noropatrol [grant code203268/Z/16/Z]. Additional funding is acknowledged from Public Health England (PHE) which is an executive agency of the Department of Health and Social Care (DHSC) and National Institute for Health USA (NIAID 1R01 AI148260). CoMix is funded by the EU Horizon 2020 Research and Innovations Programme - project EpiPose (Epidemic Intelligence to Minimize COVID-19s Public Health, Societal and Economical Impact No 101003688) and by the Medical Research Council (Understanding the dynamics and drivers of the COVID-2019 epidemic using real-time outbreak analytics MC_PC 19065).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The research was exempt from ethical approval because it is a simulation study, no data were collected as part of this research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Some text was edited to provide further context, and estimates of R0 were added to each time frame of the COVID-19 pandemic.

Data Availability

The code and data used to conduct these analyses are found at https://github.com/kath-o-reilly/norovirus_NPIs. For data access to the SGSS data used in the study applicants can apply to the PHE team by emailing noroOBK@phe.gov.uk

https://github.com/kath-o-reilly/norovirus_NPIs

  • Abbreviations

    IID
    Infectious Intestinal Disease
    NPI
    Non pharmaceutical interventions
    SEIR
    susceptible-exposed-infectious-recovered
    SGSS
    Second Generation Surveillance System
    UK
    United Kingdom
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted September 03, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study
    Kathleen M O’Reilly, Frank Sandman, David Allen, Christopher I Jarvis, Amy Gimma, Amy Douglas, Lesley Larkin, Kerry LM Wong, Marc Baguelin, Ralph S Baric, Lisa C Lindesmith, Richard A Goldstein, Judith Breuer, W John Edmunds
    medRxiv 2021.07.09.21260277; doi: https://doi.org/10.1101/2021.07.09.21260277
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Predicted Norovirus Resurgence in 2021-2022 Due to the Relaxation of Nonpharmaceutical Interventions Associated with COVID-19 Restrictions in England: A Mathematical Modelling Study
    Kathleen M O’Reilly, Frank Sandman, David Allen, Christopher I Jarvis, Amy Gimma, Amy Douglas, Lesley Larkin, Kerry LM Wong, Marc Baguelin, Ralph S Baric, Lisa C Lindesmith, Richard A Goldstein, Judith Breuer, W John Edmunds
    medRxiv 2021.07.09.21260277; doi: https://doi.org/10.1101/2021.07.09.21260277

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Epidemiology
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1093)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
    • Epidemiology (9758)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2304)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1554)
    • Health Policy (732)
    • Health Systems and Quality Improvement (602)
    • Hematology (236)
    • HIV/AIDS (501)
    • Infectious Diseases (except HIV/AIDS) (11634)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (257)
    • Neurology (2140)
    • Nursing (134)
    • Nutrition (335)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1172)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (309)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2173)
    • Public and Global Health (4648)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (455)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (210)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)